In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Biomatrix launch Synvist through Novartis in Mexico and Peru
FDA approves dual-therapy nebulizer solution
FDA approves Repronex new drug application
FDA approves avelox for respiratory illnesses
FDA approves Elan's migraine drug Frova
FDA Approves Progestin Contraceptive Yasmin